organization · Reporting owner
BRAC Lending Group LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NRX Pharmaceuticals, Inc.
Report date May 24, 2021 · Filed June 04, 2021 · Amendment
Section 16 reporting ended · disclosed 2021-06-04. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 590,435 |
Reported balance
After 2021-05-24 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2021-05-24 · Disposition to issuer · Disposed 869,565 · Balance 590,435 F1: Form 4 filed on May 25, 2021, erroneously reported 562,435 shares beneficially owned in Column 5. This amendment is being filed to correct the total shares beneficially owned in Column 5. |
Filing footnotes · ownership attribution and instrument terms
F1: Form 4 filed on May 25, 2021, erroneously reported 562,435 shares beneficially owned in Column 5. This amendment is being filed to correct the total shares beneficially owned in Column 5.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 24, 2021 Filed May 25, 2021 20:02 UTC | NRX Pharmaceuticals, Inc. BRPA · Entity 6523 | Disposition to issuerCommon Stock | 869,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-21-000209 · edgar.xml · nonDerivative · entry 1 BRAC Lending Group LLC · CIK 0001759828 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,435 Read SEC document |
| May 24, 2021 Filed Jun 4, 2021 09:40 UTC Amendment | NRX Pharmaceuticals, Inc. BRPA · Entity 6523 | Disposition to issuerCommon Stock | 869,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-21-000243 · edgar.xml · nonDerivative · entry 1 BRAC Lending Group LLC · CIK 0001759828 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 590,435 F1 · balance_after: Form 4 filed on May 25, 2021, erroneously reported 562,435 shares beneficially owned in Column 5. This amendment is being filed to correct the total shares beneficially owned in Column 5. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.